Immunological Profiles in Parry-Romberg Syndrome: A Case-Control Study

Area of Science:

• Immunology
• Dermatology
• Genetics

Background:

• Parry-Romberg syndrome (PRS) is a rare craniofacial disorder.
• PRS may be part of a broader spectrum of sclerodermic diseases.
• Immunological profiles of PRS patients are not well-understood.

Purpose of the Study:

• To investigate the immunological profile of Parry-Romberg syndrome (PRS).
• To compare the immune cell phenotypes and cytokine concentrations in PRS patients versus scleroderma (CTR) patients.
• To explore potential therapeutic targets for PRS based on immune system differences.

Main Methods:

• Case-control study comparing one PRS patient with one scleroderma patient.
• Flow cytometry analysis of B lymphocyte, T lymphocyte, and monocyte phenotypes and functions in peripheral blood mononuclear cells (PBMCs).
• Luminex assay to measure cytokine concentrations in PBMC supernatants, plasma, and saliva.

Main Results:

• T and B lymphocytes showed similar activation in unstimulated PRS and CTR cells, but differed upon antigen stimulation.
• T helper 17 (Th17) lymphocytes were expanded in PRS compared to CTR.
• Increased Th17 cell percentage in PRS correlated with higher interleukin-17 (IL-17) concentration.

Conclusions:

• This is the first study comparing immunological profiles of PRS and scleroderma patients.
• Expanded Th17 cells and elevated IL-17 in PRS suggest potential efficacy of anti-IL-17 receptor monoclonal antibodies.
• Further research with larger patient cohorts is necessary to validate these findings and therapeutic implications.